SCHEMBL8377384

SCHEMBL8377384

CC(C)c1c(OCCNC(=O)OC(C)(C)C)noc1-c1ccc(F)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.41
PDK2 Q15119 1/20 0.40
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
IDO1 P14902 3/20 0.37
ACVR1B P36896 1/20 0.36
TGFBR1 P36897 1/20 0.36
ACVRL1 P37023 1/20 0.36
EGFR P00533 1/20 0.36
ITK Q08881 1/20 0.36
AAK1 Q2M2I8 3/20 0.35
BRD4 O60885 1/20 0.35
GABRA5 P31644 1/20 0.35
AXL P30530 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377390 0.83 IDO1 (0.46) PDK2CA12CA1CA2CA9
SCHEMBL8377409 0.81 PDK2 (0.41) SCN9APDK2CA12CA1CA2
SCHEMBL8375760 0.81 IDO1 (0.43) SCN9APDK2CA12CA1CA2
SCHEMBL8377351 0.80 CA12 (0.40) SCN9APDK2CA12CA1CA2
SCHEMBL8376442 0.79 LMNA (0.40) SCN9ACA12CA1CA2CA9
SCHEMBL8375796 0.78 ADORA2A (0.43) SCN9ACA12CA1CA2CA9
SCHEMBL8380153 0.78 ACKR3 (0.44) SCN9APDK2ALOX5APFEN1CA12
SCHEMBL8375676 0.77 RAB9A (0.41) SCN9APDK2CA12CA1CA2
SCHEMBL8378805 0.77 IDO1 (0.42) SCN9ACA12CA1CA2CA9
SCHEMBL6990907 0.76 CA12 (0.45) SCN9APDK2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed